EAM
Eventide Asset Management Portfolio holdings
AUM
$5.71B
This Quarter Return
+18.78%
1 Year Return
+51.18%
3 Year Return
+209.28%
5 Year Return
+283.63%
10 Year Return
+1,480.39%
AUM
$5.71B
AUM Growth
+$5.71B
(+14%)
Cap. Flow
+$6.57M
Cap. Flow
% of AUM
0.12%
Top 10 Holdings %
Top 10 Hldgs %
24.42%
Holding
257
New
40
Increased
127
Reduced
58
Closed
20
Top Buys
| 1 |
EQT Corp
EQT
|
$28.9M |
| 2 |
Frontdoor
FTDR
|
$28.5M |
| 3 |
Chewy
CHWY
|
$27.8M |
| 4 |
Verisk Analytics
VRSK
|
$26M |
| 5 |
Lam Research
LRCX
|
$25.3M |
Top Sells
| 1 |
Celldex Therapeutics
CLDX
|
$48.8M |
| 2 |
Micron Technology
MU
|
$44.8M |
| 3 |
Snowflake
SNOW
|
$36.5M |
| 4 |
Evolent Health
EVH
|
$22.4M |
| 5 |
Inspire Medical Systems
INSP
|
$19.4M |
Sector Composition
| 1 | Healthcare | 37.06% |
| 2 | Technology | 18.81% |
| 3 | Industrials | 18.23% |
| 4 | Consumer Discretionary | 7.45% |
| 5 | Utilities | 4.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
EXL Service
EXLS
$7.05B
| $17.3M | 0.3% |
394,930
-2,130
| -0.5% | -$93.3K |
|
102
Rockwell Automation
ROK
$38.1B
| $16.9M | 0.3% |
50,982
+787
| +2% | +$261K |
|
103
BridgeBio Pharma
BBIO
$9.91B
| $16.6M | 0.29% |
384,231
-147,961
| -28% | -$6.39M |
|
104
Equity Residential
EQR
$24.7B
| $16.6M | 0.29% |
206,835
-183,645
| -47% | -$14.7M |
|
105
Disc Medicine
IRON
$2.14B
| $16.3M | 0.29% |
308,030
+126,212
| +69% | +$6.68M |
|
106
IDEAYA Biosciences
IDYA
$2.26B
| $16.2M | 0.28% |
771,844
| – | – |
|
107
Acadia Pharmaceuticals
ACAD
$4.34B
| $15.7M | 0.28% |
728,437
-124,408
| -15% | -$2.68M |
|
108
Xylem
XYL
$34B
| $14.5M | 0.25% |
112,302
+1,386
| +1% | +$179K |
|
109
Fair Isaac
FICO
$36.5B
| $14.3M | 0.25% |
7,842
+8
| +0.1% | +$14.6K |
|
110
Broadcom
AVGO
$1.42T
| $14.2M | 0.25% |
50,971
+19,384
| +61% | +$5.39M |
|
111
AvalonBay Communities
AVB
$27.2B
| $14M | 0.24% |
+68,675
| New | +$14M |
|
112
Revolution Medicines
RVMD
$7.43B
| $13.7M | 0.24% |
372,229
| – | – |
|
113
McCormick & Company Non-Voting
MKC
$18.7B
| $13.6M | 0.24% |
179,650
+8,599
| +5% | +$652K |
|
114
United Therapeutics
UTHR
$17.7B
| $13.6M | 0.24% |
47,241
| – | – |
|
115
American Express
AXP
$225B
| $13.3M | 0.23% |
40,710
+15,448
| +61% | +$5.04M |
|
116
Syndax Pharmaceuticals
SNDX
$1.39B
| $13.2M | 0.23% |
1,414,081
+236,019
| +20% | +$2.21M |
|
117
Pool Corp
POOL
$11.4B
| $11.8M | 0.21% |
40,390
+1,471
| +4% | +$429K |
|
118
Intuit
INTU
$187B
| $11.8M | 0.21% |
14,796
+2,365
| +19% | +$1.88M |
|
|
MTSR
119
Metsera, Inc. Common Stock
MTSR
$3.75B
| $11.3M | 0.2% |
396,160
+146,160
| +58% | +$4.16M |
|
120
Home Depot
HD
$406B
| $11.2M | 0.2% |
29,203
+6,315
| +28% | +$2.43M |
|
121
Bruker
BRKR
$4.45B
| $11.2M | 0.2% |
272,324
+135,924
| +100% | +$5.6M |
|
122
S&P Global
SPGI
$165B
| $11M | 0.19% |
20,700
+2,165
| +12% | +$1.15M |
|
123
Avidity Biosciences
RNA
$6.12B
| $10.7M | 0.19% |
375,924
| – | – |
|
124
Akero Therapeutics
AKRO
$3.65B
| $10.7M | 0.19% |
200,000
-534
| -0.3% | -$28.5K |
|
125
Linde
LIN
$221B
| $10.6M | 0.19% |
22,460
+283
| +1% | +$134K |
|